|
Market Closed -
Nasdaq
16:00:00 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 4.630 USD | -3.14% |
|
+14.89% | +13.20% |
| 09-21 | Recursion Pharmaceuticals, Inc. Grants Tempus Ai, Inc. Non-Exclusive License for Rna Foundation Model | CI |
| 09-21 | Tempus AI, Recursion Extend Data License, Amend Fee Structure | MT |
| Market Cap | 2.48B 2.2B 2.06B 1.87B 3.53B 239B 3.56B 24.77B 9.64B 122B 9.32B 9.12B 393B | P/E 2026 * |
-5.22x | P/E 2027 * | -5.33x |
|---|---|---|---|---|---|
| Enterprise Value | 2.1B 1.86B 1.74B 1.58B 2.98B 202B 3B 20.91B 8.13B 103B 7.87B 7.7B 331B | EV / Sales 2026 * |
54x | EV / Sales 2027 * | 43.1x |
| Free-Float |
97.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RXRX | Delayed | |
CBOE
| RXRX | Real-time | |
|
Mexican S.E.
| RXRX * | End-of-day quote |
Last Transcript: Recursion Pharmaceuticals, Inc.
| 1 day | -2.48% | ||
| 1 week | +14.89% | ||
| Current month | +12.11% | ||
| 1 month | +27.55% | ||
| 3 months | +16.92% | ||
| 6 months | +46.98% | ||
| Current year | +13.20% |
| 1 week | 3.96 |  | 5.19 |
| 1 month | 3.1 | | 5.19 |
| Current year | 2.77 | | 5.24 |
| 1 year | 2.77 | | 7.18 |
| 3 years | 2.77 | | 15.74 |
| 5 years | 2.77 | | 21.19 |
| 10 years | 2.77 | | 42.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Najat Khan
CEO | Chief Executive Officer | 43 | 2025-12-31 |
Ben Taylor
DFI | Director of Finance/CFO | 48 | 2024-11-19 |
Vicki Goodman
CTO | Chief Tech/Sci/R&D Officer | 57 | 2026-04-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Blake Borgeson
BRD | Director/Board Member | 44 | 2013-11-03 |
Dean Li
BRD | Director/Board Member | 62 | 2013-11-03 |
Zavain Dar
BRD | Director/Board Member | 37 | 2016-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Free | Director | 4,607 | 0.0009% | ||
| 10/1/26 | Free | Founder | 3,378 | 0.0006% | ||
| 9/15/26 | Tax | Chief Financial Officer | -5,396 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.14% | +14.89% | -16.27% | -34.14% | 2.48B | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| -1.53% | -2.93% | +21.06% | +76.02% | 58.81B | |
| -0.07% | +0.28% | +6.78% | +34.45% | 48.45B | |
| -3.76% | -2.25% | +329.09% | +698.20% | 42.84B | |
| -2.30% | -3.35% | +26.81% | +30.88% | 42.79B | |
| +0.31% | -0.68% | +5.30% | +108.64% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -1.96% | -2.88% | -8.97% | -13.92% | 24.05B | |
| Average | -0.98% | +1.26% | +45.73% | +107.32% | 39.68B | |
| Weighted average by Cap. | -0.37% | -0.44% | +54.96% | +128.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.81M 34.45M 32.24M 29.22M 55.18M 3.74B 55.58M 387M 151M 1.91B 146M 143M 6.14B | 52.38M 46.49M 43.51M 39.44M 74.48M 5.05B 75.02M 523M 203M 2.58B 197M 192M 8.28B |
| Net income | -465M -413M -386M -350M -661M -44.82B -666M -4.64B -1.8B -22.87B -1.75B -1.71B -73.51B | -481M -427M -399M -362M -683M -46.33B -688M -4.79B -1.86B -23.63B -1.8B -1.77B -75.97B |
| Net Debt | -388M -344M -322M -292M -551M -37.36B -555M -3.87B -1.5B -19.06B -1.45B -1.42B -61.26B | -227M -201M -188M -171M -322M -21.85B -325M -2.26B -880M -11.15B -851M -833M -35.84B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-06 | US$4.630 | -3.14% | 71,105,964 |
| 26-10-05 | US$4.780 | +16.02% | 67,278,674 |
| 26-10-02 | US$4.120 | +1.23% | 18,839,987 |
| 26-10-01 | US$4.070 | -1.45% | 17,484,139 |
| 26-09-30 | US$4.130 | +2.48% | 32,785,908 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RXRX Stock
Select your edition
All financial news and data tailored to specific country editions
